Peer Review History
| Original SubmissionMay 9, 2025 |
|---|
|
Dear Dr. Mengistu, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please note that we have only been able to secure a single reviewer to assess your manuscript. We are issuing a decision on your manuscript at this point to prevent further delays in the evaluation of your manuscript. Please be aware that the editor who handles your revised manuscript might find it necessary to invite additional reviewers to assess this work once the revised manuscript is submitted. However, we will aim to proceed on the basis of this single review if possible.The reviewer has identified matters requiring your attention before your study can be published, particularly regarding methodological and study design concerns, as well as regarding the discussed interpretation of results. Please ensure you address each of the reviewer's comments when revising your manuscript. These can be found below and in the attached file. Please submit your revised manuscript by Aug 24 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Hugh Cowley Staff Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements.-->--> -->-->Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at -->-->https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and -->-->https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf-->--> -->-->2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse.-->--> -->-->3. Thank you for uploading your study's underlying data set. Unfortunately, the repository you have noted in your Data Availability statement does not qualify as an acceptable data repository according to PLOS's standards.-->--> -->-->At this time, please upload the minimal data set necessary to replicate your study's findings to a stable, public repository (such as figshare or Dryad) and provide us with the relevant URLs, DOIs, or accession numbers that may be used to access these data. For a list of recommended repositories and additional information on PLOS standards for data deposition, please see https://journals.plos.org/plosone/s/recommended-repositories.-->--> -->-->4. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.-->?> 5. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Reviewer #1: attached a file since it is too big. in summary: Apply advanced resampling methods beyond SMOTE, such as: SMOTEENN or SMOTETomek to reduce noise and improve class balance. Use class weighting in algorithms (e.g., class_weight='balanced') to better handle imbalanced classes. Consider focal loss to focus the model on hard-to-classify LARC users. Use leave-one-country-out cross-validation to test geographic generalizability. Present country-wise performance to highlight regional variation in model effectiveness. Tone down claims like “strong predictive capability” given modest AUC (~0.72). Emphasize precision-recall tradeoffs more than AUC in this imbalanced context. Add partial dependence plots or real-life scenarios to make SHAP results more interpretable. Eliminate repetitive phrases like “data-driven” and “actionable insights.” Improve figure captions (especially for ROC and PR curves). Expand on SHAP force plots with a clearer explanation of example cases. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Dear Dr. Mengistu, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== ACADEMIC EDITOR: Please respond to all reviewers comments ============================== Please submit your revised manuscript by Dec 18 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Ahmed Mohamed Maged, MD Academic Editor PLOS ONE Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: Major Comments 1. Implausible Model Performance – Possible Data Leakage Reporting an AUC-ROC of 1.00 for Random Forest and 0.99 for other models is highly implausible for behavioral survey data with 3.3% positive class prevalence. Such performance almost certainly indicates data leakage or resampling before train/test split. Please clarify whether SMOTEENN resampling was applied before or within cross-validation folds. An external validation or leave-one-country-out (LOCO) approach is essential to confirm true predictive ability. 2. Validation and Generalizability Stratified cross-validation across a pooled dataset ignores geographic heterogeneity. Given that the dataset covers nine diverse countries, performance may be inflated by within-country homogeneity. Please add either: LOCO validation results, or Per-country AUC, precision, and recall to assess model transferability. Without this, the model’s regional claims are unsupported. 3. Feature Selection and Conceptual Interpretation Religion, marital status, and urban/rural residence were excluded for “low SHAP importance,” yet decades of evidence show these are key determinants of contraceptive behavior in SSA. Their exclusion likely reflects model bias or mis-specification rather than true irrelevance. The authors should: Reintroduce these variables in sensitivity analyses, or Discuss the implications of excluding sociocultural predictors in the limitations. 4. Overstatement of Findings The discussion repeatedly claims “unprecedented predictive capability” and “perfect discrimination.” Such language is misleading and inconsistent with the modest performance (AUC ≈ 0.72) before tuning. Please temper these statements and contextualize results within the limits of secondary, cross-sectional data. 5. Methodological Transparency The manuscript lacks clarity on several key analytical steps: Which variables had >20% missingness and were excluded? Were imputations performed separately per country or on pooled data? How was the k parameter in k-NN imputation selected? These details are critical for reproducibility. 6. Interpretation of SHAP Values SHAP importance scores are reported, but their direction and implications are not clearly discussed. Please include partial dependence or SHAP summary plots showing how key variables (e.g., age, household size) influence LARC use probability. Discuss SHAP limitations in sociobehavioral contexts — interpretability is not causality. 7. Policy Implications The policy recommendations (e.g., “mobile clinics for young women in large households”) are reasonable but not strongly derived from the model. Please link each recommendation explicitly to specific predictor findings or patterns in the data. Minor Comments Language and Style: The text is overly verbose, with frequent repetition of “data-driven” and “actionable insights.” Simplify and streamline technical descriptions. Figures and Captions: Figures (e.g., ROC and PR curves) require clearer captions explaining key takeaways and which models are being compared. Tables: Table 7 (showing perfect performance) contradicts earlier Table 6 (AUC = 0.72). Please reconcile or explain this discrepancy. Statistical Reporting: Include 95% confidence intervals for AUC-ROC using DeLong’s test or bootstrapping. Consider including PR-AUC, which is more appropriate for imbalanced data. Ethical and Data Section: Ethical compliance is satisfactory, but the description of data harmonization across countries could be expanded for clarity. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #2: (No Response) Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #2: No Reviewer #3: (No Response) ********** Reviewer #2: The manuscript presents an ambitious application of machine-learning (ML) methods to predict long-acting reversible contraceptive (LARC) use across Sub-Saharan Africa using PMA survey data. In its current form, it reads as a technically dense modeling exercise rather than a rigorously validated, policy-relevant study. 1. Reporting AUC-ROC = 1.00 with F1 = 0.98 for Random Forest and near-perfect metrics for other ensembles is statistically implausible for noisy, cross-national survey data with a 3.3 % minority class. The results suggest severe data leakage or overfitting (e.g., imputation applied before train-test split, SMOTE/SMOTEENN applied to the entire dataset, or lack of country-level separation). A re-run with strictly nested cross-validation and leave-one-country-out testing is essential. Confidence intervals for AUC and F1 should be reported. 2. Given the extreme class imbalance (3.3 % positive), AUC and accuracy are insufficient. Report precision–recall AUC, Matthews correlation coefficient, and calibration plots. 3. Discuss clinical/operational trade-offs (false-positive vs. false-negative cost) in the context of limited health resources. 4. The SHAP interpretation remains superficial. The authors must demonstrate how household size or age at first contraceptive use can be operationalized in interventions. 5. Present case-level SHAP examples tied to real-world decision-making (e.g., outreach prioritization) instead of generic force plots. 6. Claims such as “unprecedented predictive capability” and “ideal for deployment” are not supported. 7. The manuscript is verbose, with repetitive phrasing (“data-driven,” “actionable insights,” “transformative potential”). A professional language edit is recommended. 8. Acronyms (MLP, SHAP, SMOTEENN) should be defined once and used consistently. Reviewer #3: I believe the authors took all comments and suggestions into account when reviewing and re-submitting the manuscript. Even though not all the suggestions were taken, they gave reasons why they did not accept the suggestion. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 2 |
|
Insights into Long-Acting Reversible Contraceptive Practices in Sub-Saharan Africa: A Machine Learning Perspective PONE-D-25-24936R2 Dear Dr. Mengistu, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Ahmed Mohamed Maged, MD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #2: (No Response) ********** Reviewer #2: (No Response) ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-25-24936R2 PLOS One Dear Dr. Mengistu, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Ahmed Mohamed Maged Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .